OncoCyte Corporation (OCX)
3.19
0.41 (14.75%)
At close: Mar 04, 2025, 3:59 PM
3.10
-2.67%
After-hours: Mar 04, 2025, 07:06 PM EST
OncoCyte Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 9.43M | 19.99M | 35.6M | 7.14M | 22.07M | 8.03M | 7.6M | 10.17M | 8M | 257K | 101K |
| Short-Term Investments | n/a | 433K | 904K | 675K | 379K | 428K | 760K | 2.24M | 2.54M | 3.28M | 4.63M |
| Long-Term Investments | n/a | 1.7M | 1.7M | 13.42M | 10.96M | n/a | n/a | n/a | n/a | n/a | -1.57M |
| Other Long-Term Assets | 2.16M | 2.07M | 1.96M | 1.94M | 2.21M | 262K | 120K | 75K | n/a | n/a | 1.57M |
| Receivables | 484K | 2.01M | 1.44M | 203K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | 2.12M | 304K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 782K | 3.1M | 3.85M | 1.21M | 505K | 282K | 336K | 570K | 385K | 114K | 120K |
| Total Current Assets | 10.7M | 25.54M | 39.14M | 9.23M | 22.96M | 8.64M | 8.53M | 12.7M | 10.93M | 3.65M | 4.85M |
| Property-Plant & Equipment | 5.44M | 10.85M | 8.53M | 6.52M | 3.73M | 614K | 822K | 688K | 576K | 118K | 148K |
| Goodwill & Intangibles | 56.59M | 61.63M | 109.93M | 24.2M | n/a | n/a | 746K | 988K | 1.23M | 1.47M | 1.71M |
| Total Long-Term Assets | 64.19M | 74.56M | 120.42M | 46.19M | 16.9M | 876K | 1.69M | 1.75M | 1.81M | 2.71M | 3.44M |
| Total Assets | 74.89M | 100.09M | 159.56M | 55.42M | 39.86M | 9.52M | 10.22M | 14.45M | 12.73M | 6.36M | 8.29M |
| Account Payables | 953K | 1.25M | 1.81M | 432K | 469K | 166K | 175K | 422K | 285K | 144K | 103K |
| Deferred Revenue | n/a | n/a | n/a | 5.15M | n/a | n/a | n/a | n/a | -847K | n/a | n/a |
| Short-Term Debt | 665K | 1.63M | 2.95M | 3.23M | 1.58M | 1.57M | 1.48M | 404K | n/a | 5.89M | 2.96M |
| Other Current Liabilities | 5.58M | 9.22M | 9.36M | 5.33M | 2.39M | 3.83M | 2.8M | 3.45M | 2.03M | 1.4M | 1.61M |
| Total Current Liabilities | 7.19M | 12.11M | 14.12M | 9M | 4.44M | 5.56M | 4.45M | 4.28M | 2.31M | 7.43M | 4.67M |
| Long-Term Debt | 2.2M | 2.73M | 3.54M | 5.82M | 4.58M | 534K | 1.36M | 310K | n/a | n/a | n/a |
| Other Long-Term Liabilities | 39.9M | 50.96M | 76.68M | 7.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 42.1M | 53.69M | 80.23M | 12.94M | 4.58M | 534K | 1.36M | 310K | n/a | n/a | n/a |
| Total Liabilities | 49.3M | 65.8M | 94.35M | 21.94M | 9.02M | 6.09M | 5.81M | 4.58M | 2.31M | 7.43M | 4.67M |
| Total Debt | 2.87M | 3.54M | 5.68M | 8.63M | 5.94M | 1.72M | 2.5M | 512K | 847K | 5.89M | 2.96M |
| Common Stock | 310.3M | 294.93M | 252.95M | 157.16M | 124.58M | 74.74M | 59.97M | 45.82M | 34.9M | 15.15M | 15.4M |
| Retained Earnings | -289.88M | -260.68M | -187.77M | -123.68M | -93.75M | -71.32M | -54.68M | -35.3M | -24.13M | -15.4M | -10.41M |
| Comprehensive Income | 49K | 39K | 37K | 0.00 | n/a | n/a | -888K | -654K | -350K | -822K | -1.37M |
| Shareholders Equity | 25.59M | 34.29M | 65.22M | 33.48M | 30.84M | 3.42M | 4.4M | 9.86M | 10.42M | -1.07M | 3.62M |
| Total Investments | 1.7M | 433K | 904K | 14.09M | 11.34M | 428K | 760K | 2.24M | 2.54M | 3.28M | 4.63M |